ArticleAmerican journal of cancer research2021
Repurposing of posaconazole as a hedgehog/SMO signaling inhibitor for embryonal rhabdomyosarcoma therapy.
Jingkai Sun et al.PubMed ↗Full text ↗
No numbers read from the abstract.
1 paper cites it
this papercites it